Immunotherapy in CRC Depends on Identifying Predictive Biomarkers – Targeted Oncology
Targeted Oncology |
Immunotherapy in CRC Depends on Identifying Predictive Biomarkers
Targeted Oncology “There are studies in the first line as well as the adjuvant setting, but we do not have data on those studies. We are starting to see broader testing of solid tumor types in mismatch repair by immunohistochemistry and polymerase chain reaction. We’re … |
Targeted Oncology |
Immunotherapy in CRC Depends on Identifying Predictive Biomarkers
Targeted Oncology “There are studies in the first line as well as the adjuvant setting, but we do not have data on those studies. We are starting to see broader testing of solid tumor types in mismatch repair by immunohistochemistry and polymerase chain reaction. We’re … |
STAT |
Pharmalittle: Biogen argues investors overreacted; AstraZeneca wins a key immunotherapy approval
STAT ood morning, everyone, and welcome to another working week. Those of you on our side of the pond had, of course, an extended respite thanks to a federal holiday, and we hope your time was relaxing and invigorating, because that oh-so-familiar routine … US FDA Approves AstraZeneca’s Immunotherapy for Lung CancerJournal of Clinical Pathways AstraZeneca PLC (NYSE:AZN) won crucial approval from US regulators for use in lung cancerBenchmark Monitor |
Xconomy |
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy
Xconomy At a time when uncertainty again swirls around the development of Alzheimer’s disease drugs, research continues in new ways. Through an alliance this morning, Voyager Therapeutics will team with AbbVie to try to use gene therapy tools to help attack … AbbVie steers past the wreckage, reserves $224M to kick off once-and-done gene therapy with Voyager to fight …Endpoints News AbbVie and Voyager Therapeutics Announce Global Strategic Collaboration to Develop Potential New Treatments for …Markets Insider AbbVie doubles down on tau with Voyager Alzheimer’s dealFierceBiotech Seeking Alpha all 6 news articles » |
Genetic Literacy Project |
CRISPR as a ‘medical sleuth’: Gene-editing tool could detect Zika, Ebola and cancer
Genetic Literacy Project Some of the world’s leading CRISPR labs have, independently, tweaked CRISPR — adding bursts of light here and rings of DNA there — in ways that could make it even more of a research powerhouse and, possibly, a valuable medical sleuth, able to detect … |